Big Week Ahead For Stocks… And Emergent’s Mpox Approval 8/30/24
August trading is in the books, and after a rough start to the month, stocks managed to rebound. But with a big week on deck, can the bounce back continue? Plus Biotech company Emergent Bio getting FDA approval for its smallpox vaccine to treat mpox. What it could mean for Emergent’s future and the space as a whole. Fast Money Disclaimer
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
August trading is in the books, and after a rough start to the month, stocks managed to rebound. But with a big week on deck, can the bounce back continue? Plus Biotech company Emergent Bio getting FDA approval for its smallpox vaccine to treat mpox. What it could mean for Emergent’s future and the space as a whole.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.